Related Experiment Video
Updated: Jul 16, 2026

Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 25, 2016
[The sedativ-hypnotic principle of hops]
R Hänsel1, R Wohlfart, H Schmidt
1Institut für Pharmakognosie und Phytochemie der Freien Universität Berlin.
The sedative hop constituent, 2-methyl-3-butene-2-ol, increases with storage time after drying. Pharmacologically relevant concentrations are achievable in tea and bath preparations, but not typically in marketed hop extracts or dragees.
Area of Science:
- Analytical Chemistry
- Pharmacognosy
- Organic Chemistry
Context:
- Hops (Humulus lupulus) contain numerous compounds, including 2-methyl-3-butene-2-ol, a sedative constituent.
- The concentration of 2-methyl-3-butene-2-ol in hops and hop products can vary significantly based on processing and storage.
- Understanding the stability and distribution of this compound is crucial for its potential therapeutic applications.
Purpose:
- To describe a gas chromatographic method for quantifying 2-methyl-3-butene-2-ol.
- To determine the concentration of 2-methyl-3-butene-2-ol in various hop matrices, including fresh hops, dried hops, hop extracts, and pharmaceutical preparations.
- To assess the potential for achieving pharmacologically relevant concentrations of this compound in different preparations.
Summary:
- A quantitative gas chromatographic method was developed for 2-methyl-3-butene-2-ol.
- Concentrations of 2-methyl-3-butene-2-ol increase from trace levels in fresh hops to approximately 0.15% after 2 years of room temperature storage.
- Marketed hop extracts and sedative dragees contain low levels, while sedative bath preparations show higher concentrations.
Impact:
- Pharmacologically relevant concentrations of 2-methyl-3-butene-2-ol can be achieved in hop-based tea and bath preparations.
- Further research is needed to determine if alpha-acids metabolize into 2-methyl-3-butene-2-ol in vivo, which could impact the efficacy of certain sedative products.
More Related Videos
07:28An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila
Published on: April 15, 2015
06:33Method for Simultaneous fMRI/EEG Data Collection during a Focused Attention Suggestion for Differential Thermal Sensation
Published on: January 5, 2014
Related Concept Videos
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Barbiturates
Management of Insomnia
Depressants
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...